Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone.
Harari S, Caminati A, Confalonieri M, Poletti V, Vancheri C, Pesci A, Rogliani P, Luppi F, Agostini C, Rottoli P, Sanduzzi Zamparelli A, Sebastiani A, Della Porta R, Salton F, Messore B, Tomassetti S, Rosso R, Biffi A, Puxeddu E, Cerri S, Cinetto F, Refini RM, Bocchino M, Di Michele L, Specchia C, Albera C; ILDINET (Interstitial Lung Diseases Italian Network). Harari S, et al. Among authors: cinetto f. Clin Respir J. 2019 Mar;13(3):166-173. doi: 10.1111/crj.12999. Clin Respir J. 2019. PMID: 30675755 Free article.
3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a glycogen synthase kinase-3 inhibitor, displays therapeutic properties in a mouse model of pulmonary inflammation and fibrosis.
Gurrieri C, Piazza F, Gnoato M, Montini B, Biasutto L, Gattazzo C, Brunetta E, Cabrelle A, Cinetto F, Niero R, Facco M, Garbisa S, Calabrese F, Semenzato G, Agostini C. Gurrieri C, et al. Among authors: cinetto f. J Pharmacol Exp Ther. 2010 Mar;332(3):785-94. doi: 10.1124/jpet.109.153049. Epub 2009 Dec 3. J Pharmacol Exp Ther. 2010. PMID: 19959748
Efficacy of pirfenidone for idiopathic pulmonary fibrosis: An Italian real life study.
Harari S, Caminati A, Albera C, Vancheri C, Poletti V, Pesci A, Luppi F, Saltini C, Agostini C, Bargagli E, Sebastiani A, Sanduzzi A, Giunta V, Della Porta R, Bandelli GP, Puglisi S, Tomassetti S, Biffi A, Cerri S, Mari A, Cinetto F, Tirelli F, Farinelli G, Bocchino M, Specchia C, Confalonieri M. Harari S, et al. Among authors: cinetto f. Respir Med. 2015 Jul;109(7):904-13. doi: 10.1016/j.rmed.2015.04.010. Epub 2015 Apr 25. Respir Med. 2015. PMID: 25962649 Free article.
Clinical profile associated with infections in patients with chronic lymphocytic leukemia. Protective role of immunoglobulin replacement therapy.
Visentin A, Compagno N, Cinetto F, Imbergamo S, Zambello R, Piazza F, Semenzato G, Trentin L, Agostini C. Visentin A, et al. Among authors: cinetto f. Haematologica. 2015 Dec;100(12):e515-8. doi: 10.3324/haematol.2015.126763. Epub 2015 Aug 20. Haematologica. 2015. PMID: 26294735 Free PMC article. No abstract available.
Rituximab in refractory sarcoidosis: a single centre experience.
Cinetto F, Compagno N, Scarpa R, Malipiero G, Agostini C. Cinetto F, et al. Clin Mol Allergy. 2015 Sep 1;13(1):19. doi: 10.1186/s12948-015-0025-9. eCollection 2015. Clin Mol Allergy. 2015. PMID: 26330764 Free PMC article.
77 results